FS50237119: Difference between revisions
From FOIwiki
Jump to navigationJump to search
Alex skene (talk | contribs) CSV import |
Alex skene (talk | contribs) m Text replace - "DNDecision1" to "DNDecision" |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{DNSummaryBox | {{DNSummaryBox | ||
|dn_ref=FS50237119 | |dn_ref=FS50237119 | ||
|dn_date=18 | |dn_date=18 February 2010 | ||
|dn_pa=Medicines and Healthcare Products Regulatory Agency | |dn_pa=Medicines and Healthcare Products Regulatory Agency | ||
|dn_summary=The complainant made a request under the Freedom of Information Act 2000 (the | |dn_summary=The complainant made a request under the Freedom of Information Act 2000 (the “Act”) to the Medicines and Healthcare Regulatory Authority (MHRA) for information it had redacted from pages 9 to 31 of an Assessment Report setting out the findings of a study conducted on the issue of mortality rates in Linezolid treated patients. The MHRA refused to disclose the requested information upon reliance of the exemptions contained at sections 40(2) and 41(1) of the Act. The Commissioner considers that the MHRA correctly applied the exemption contained at section 41(1) of the Act to withhold the requested information. As the Commissioner found that section 41(1) of the Act was correctly engaged he did not go on to consider the MHRA’s application of section 40(2) of the Act. The Commissioner does however consider that the MHRA breached sections 1(1)(a) and (b), section 10(1) and section 17(1) in its handling of this request. This decision notice is currently under appeal to the Information Tribunal. | ||
|dn_url=http://www.ico.gov.uk/upload/documents/decisionnotices/2010/fs_50237119.pdf | |dn_url=http://www.ico.gov.uk/upload/documents/decisionnotices/2010/fs_50237119.pdf | ||
}} | }} | ||
{{DNDecision | {{DNDecision | ||
| | |dnd_section=FOI 10 | ||
| | |dnd_finding=Upheld | ||
}} | |||
{{DNDecision | |||
|dnd_section=FOI 17 | |||
|dnd_finding=Upheld | |||
}} | |||
{{DNDecision | |||
|dnd_section=FOI 41 | |||
|dnd_finding=Not upheld | |||
}} | }} | ||
Latest revision as of 22:39, 15 May 2010
Decision Summary
- Case Ref: FS50237119
- Date: 18 February 2010
- Public Authority: Medicines and Healthcare Products Regulatory Agency
- Summary: The complainant made a request under the Freedom of Information Act 2000 (the “Act”) to the Medicines and Healthcare Regulatory Authority (MHRA) for information it had redacted from pages 9 to 31 of an Assessment Report setting out the findings of a study conducted on the issue of mortality rates in Linezolid treated patients. The MHRA refused to disclose the requested information upon reliance of the exemptions contained at sections 40(2) and 41(1) of the Act. The Commissioner considers that the MHRA correctly applied the exemption contained at section 41(1) of the Act to withhold the requested information. As the Commissioner found that section 41(1) of the Act was correctly engaged he did not go on to consider the MHRA’s application of section 40(2) of the Act. The Commissioner does however consider that the MHRA breached sections 1(1)(a) and (b), section 10(1) and section 17(1) in its handling of this request. This decision notice is currently under appeal to the Information Tribunal.
- View PDF of Decision Notice: [1]
- Section of Act / Finding: FOI 10 - Complaint Upheld - Find other matching decisions
- Section of Act / Finding: FOI 17 - Complaint Upheld - Find other matching decisions
- Section of Act / Finding: FOI 41 - Complaint Not upheld - Find other matching decisions
